title: The Food and Drug Administration Safety Communication on Unintentional Injection of Soft-Tissue Filler Into Facial Blood Vessels: Important Points and Perspectives.
authors.affiliation: *Department of Dermatology, UC Davis Medical Center, Sacramento, California; Photobiomodulation Laboratory, UC Davis and Sacramento VA Medical Center, Sacramento, California; Dermatology Service, HIV Lipoatrophy Clinic, Lasers, Light and Complementary Therapy, Sacramento VA Medical Center, Sacramento, California; †Department of Dermatology, St. Louis University, St. Louis, Missouri; Laser & Dermatologic Surgery Center, Chesterfield, Missouri.
authors.forename: Jared
authors.initials: J
authors.lastname: Jagdeo
authors.forename: George
authors.initials: G
authors.lastname: Hruza
mesh_terms: D003357:Cosmetic Techniques / Q000009:adverse effects*; D000067548:Dermal Fillers / Q000008:administration & dosage*; D005145:Face / Q000098:blood supply*; D006801:Humans; D007279:Injections, Subcutaneous / Q000009:adverse effects*; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D000067548:Dermal Fillers